氟康唑类似物的研究进展

许克寒; 黄蕾; 吴俊琪; 戚麟; 金永生; 俞世冲

doi:10.3969/j.issn.1006-0111.2016.02.004

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

x 关闭永久关闭

应中央军委要求，2022年9月起，《药学实践杂志》将更名为《药学实践与服务》，双月刊，正文96页；2023年1月起，拟出版月刊，正文64页，数据库收录情况与原《药学实践杂志》相同。欢迎作者踊跃投稿！

氟康唑类似物的研究进展

许克寒, 黄蕾, 吴俊琪, 戚麟, 金永生, 俞世冲

文章导航 > 药学实践与服务 > 2016 > 34(2): 110-113,128

许克寒, 黄蕾, 吴俊琪, 戚麟, 金永生, 俞世冲. 氟康唑类似物的研究进展[J]. 药学实践与服务, 2016, 34(2): 110-113,128. doi: 10.3969/j.issn.1006-0111.2016.02.004

引用本文:

许克寒, 黄蕾, 吴俊琪, 戚麟, 金永生, 俞世冲. 氟康唑类似物的研究进展[J]. 药学实践与服务, 2016, 34(2): 110-113,128. doi: 10.3969/j.issn.1006-0111.2016.02.004

XU Kehan, HUANG Lei, WU Junqi, QI Lin, JIN Yongsheng, YU Shichong. Research progress of fluconazole derivatives[J]. Journal of Pharmaceutical Practice and Service, 2016, 34(2): 110-113,128. doi: 10.3969/j.issn.1006-0111.2016.02.004

Citation:

XU Kehan, HUANG Lei, WU Junqi, QI Lin, JIN Yongsheng, YU Shichong. Research progress of fluconazole derivatives[J]. Journal of Pharmaceutical Practice and Service, 2016, 34(2): 110-113,128. doi: 10.3969/j.issn.1006-0111.2016.02.004

氟康唑类似物的研究进展

doi: 10.3969/j.issn.1006-0111.2016.02.004

第二军医大学药学院有机化学教研室, 上海 200433

基金项目: 第二军医大学药学院药学实验中心孵化基地重点课题;本科学员创新实践能力孵化基地项目(2015YJ06)

Research progress of fluconazole derivatives

Department of Organic Chemistry, School of Pharmacy, Second Military Medical University, Shanghai 200433, China

摘要: 氟康唑是第三代三唑类抗真菌药物,具有水溶性好、广谱和低毒等优点,是临床上治疗真菌感染的首选药物。随着氟康唑耐药菌株的不断出现,研制新型氟康唑类似物成为重要的科研课题。通过对氟康唑结构的修饰,获得新型氟康唑类似物,为进一步的新药合成研究提供线索。
- 氟康唑 /
- 抗真菌药 /
- 结构修饰 /
- 合成
Abstract: Fluconazole, the third generation of triazole-antifungal drug, becomes the first choice in the treatment of fungal infection due to its broad antifungal spectrum, good water solubility and low toxicity. With an increasingly drug-resistant strain, developing new fluconazole derivatives is becoming an attractive topic. This review mainly indicates that people can get new fluconazole derivatives used by clinic through structural modification of fluconazole, which will give clues for advanced research.
- fluconazole /
- antifungal agents /
- structural modification /
- synthesis

[1]	Sobue S, Tan K, Haug-Pihale G. The effects of hepatic impairment on the pharmacokinetics of fosfluconazole and fluconazole following a single intravenous bolus injection of fosfluconazole[J]. Br J Clin Pharmacol, 2005,59(2):160-166.
[2]	Mora SJ, Cormick MP, Milanesio ME,et al. The photodynamic activity of a novel porphyrin derivative bearing a Fluconazole structure in different media and against Candida albicans[J]. Dyes Pigments, 2010, 87(3):234-240.
[3]	Zhou CH, Yu KG, Meng JP, et al. Dibenzimidazole and oniumcompound thereof, preparation method and medical use thereof:China, 101397276(A)[P].2009.
[4]	Francavilla C, Low E, Nair S, et al. Quaternary ammonium N,N-dichloroamines as topical antimicrobial agents[J]. Bioorg Med Chem Lett, 2009, 19(10):2731-2734.
[5]	Zhou CH, Mi JL, Wu J, et al. Triazole onium compound with antimicrobial activity, preparation method and medical use:China, 101391985(A)[P].2009.
[6]	Zhang YY, Mi JL, Zhou CH, et al. Synthesis of novel fluconazoliums and their evaluation for antibacterial and antifungal activities[J]. Eur J Med Chem, 2011, 46(9):4391-4402.
[7]	Sheng CQ, Zhang WN, Ji HT, et al. Structure-based optimization of azole antifungal agents by CoMFA, CoMSIA, and molecular docking[J]. J Med Chem, 2006, 49(8):2512-2525.
[8]	Chai XY, Zhang J, Yu S C, et al. Design,synthesis,and biological evaluation of novel 1-(1H-1,2,4-tri-Azole-1-yl)-2-(2,4-difluorophenyl)-3-substituted benzylamino-2-propanols[J]. Bioorg Med Chem Lett, 2009, 19(6):1811-1814.
[9]	Wang WY, Sheng CQ, Che XY, et al. Design, synthesis, and antifungal activity of novel conformationally restricted triazole derivatives[J]. Arch Pharm(Weinheim), 2009, 342(12):732-739.
[10]	Li WH, Zhao L, Tan GG, et al. Enantioseparation of the new antifungal drug iodiconazole and structually related triaditimenol analogues by CE with neutral cyclodextrin additives[J]. Chromatograp-Hia, 2011, 73(8):1009-1014.
[11]	Yu S, Chai X, Hu N, et al. Synthesis and antifungal activity of the novel triazole compounds[J]. Medchemcomm, 2013, 4(4):704-708.
[12]	Yu S, Chai X, Hu H, et al. Synthesis and antifungal evaluation of the novel triazole derivatives as inhibitors of cytochrome P45014a-demethylase[J]. Eur J Med Chem, 2010, 45(3):4435-4445.
[13]	Chai XY, Zhang J, Yu SC, et al. Design,synthesis,and biological evaluation of novel 1-(1H-1,2,4-triazole-1-yl)-2-(2,4-difluorophenyl)-3-substituted benzylamino-2-propanols[J]. Bioorg Med Chem Lett, 2009, 19(6):1811-1814.
[14]	Giraud F, Loge C, Pagniez F, et al. Design, synthesis, and evaluation of 1-(N-benzylamino)-2-phn-yl-3-(1H-1,2,4-triazol-1-yl)propan-2-ols as antifungal agents[J]. Bioorg Med Chem Lett, 2008, 18(6):1820-1824.
[15]	Giraud F, Guillon R, Loge C, et al. Synthesis and structure-activity relationships of 2-phenyl-1-[(pyridinyl-and piperidinylmethyl)amino]-3-(1H-1,2,4-triazol-1-yl) propan-2-ols as antifungal agents[J]. Bioorg Med Chem Lett, 2009, 19(2):301-304.
[16]	Gan LL, Cai JL, Zhou CH. Advances in the research of piperazine compounds as receptor ligands[J]. Chin Pharma J, 2009, 44:1361-1368.
[17]	Gan LL, Lu YH, Zhou CH. Advances in the research of piperazine compounds as enzyme inhibitors[J]. Chin J Biochem Pharm, 2009, 30:127-131.
[18]	Cai JL, Lu YH, Gan LL, et al. Recent advance in the research of piperazine-containing compounds as antimicrobial agents[J]. Chin J Antibiot, 2009, 34:454-462.
[19]	Gan LL, Zhou CH. Synthesis of azole-containing piperazine derivatives and evaluation of their antibacterial, antifungal and cytotoxic activities[J].Bull Korean Chem Soc, 2010, 31(12):3684-3692.
[20]	Na YM. Synthesis and activity of novel 1-halogenobenzylindole linked triazole derivatives as antifungal agents[J]. Bull Korean Chem Soc, 2011, 32(1):307-310.
[21]	Zhao JX, Cao YY, Quan H, et al. In vitro and in vivo activities of HQQ-3, a new triazole antifungal agent[J]. Biol Pharm Bull, 2006, 29(10):2031-2034.
[22]	Xu JM, Cao YB, Zhang J, et al. Design, synthesis and antifungal activities of novel 1,2,4-triazole derivatives[J]. Eur J Med Chem, 2011, 46(7):3142-3148.
[23]	Jiang YW, Zhang J, Cao YB, et al. Synthesis, in vitro evaluation and molecular docking studies of new triazole derivatives as antifungal agents[J]. Bioorg Med Chem Lett, 2011, 21(15):4471-4475.
[24]	Tron GC, Pirali T, Billing RA, et al. Click chemistry reaction in medicinal chemistry:applications of the 1,3-dipolar cycloaddition between azides and alkynes[J].Med Res Rev, 2008, 28(2):278-308.
[25]	WeiJJ, Wang Y, Wang XL, et al. Recent advances of1,2,3-triazole compounds in medicinal chemistry[J]. Chin Pharm J, 2011, 46:481-485.
[26]	Wang BG, Yu SC, Chai XY, et al. Design synthesis and biological evaluation of 3-substituted triazole derivatives[J]. Chin Chem Lett, 2011, 22(5):519-522.
[27]	Fang B, Zhou CH, Rao XC. Synthesis and biological activities of novel amine-derived bis-azoles as potential antibacterial and antifungal agents[J]. Eur J Med Chem, 2010, 45(9):4388-4398.
[28]	Zhou CH, Fang B, Gan LL. Benzyl chloride tertiary amine double azole antimicrobial compounds, preparation and medical use thereof:China, 101323594(B)[P].2011.
[29]	Bendaha H, Yu L, Touzani R, et al. New azole antifungal agents with novel modes of action:synthesis and biological studies of new tridentate ligands based on pyrazole and triazole[J]. Eur J Med Chem, 2011, 46(9):4117-4124.